Continues International Growth Strategy
KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the Germany-based market leader of technologies and
training methods for full-endoscopic, minimally-invasive spinal surgery,
is presenting its complete product portfolio at the 48th
Annual Meeting of the Japanese Society for Spine Surgery and Related
Research (JSSR, http://www.jssr.gr.jp/english/).
The annual meeting is currently underway running April 18-20, 2019 in
Yokohama, Japan.
Earlier this year, joimax® announced its partnership with
United Biomech Japan, Inc., who is overseeing distribution of the
complete joimax® product line throughout Japan. Approval of
the Pharmaceutical Medicals and Medical Devices Agency (PMDA) is
expected within the next couple of months.
“The Japanese market is characterized by a strong demand for innovative
products on endoscopic spinal surgery,” explained United Biomech Japan,
Inc. Executive Kazuya Oribe. “The interest at our booth is overwhelming.
There are approximately one thousand Japanese surgeons that are now
already interested in doing endoscopic spinal surgery.”
“The patients’ demand for gentle surgery methods that result in a very
quick recovery, is continuously increasing,” said joimax®
Group Founder and CEO Wolfgang Ries. “Our entrance into the Japanese
market is another milestone in expanding our global presence to offer
superior medical products. Coupled with an outstanding, international
training and education program, we’ve positioned ourselves for long-term
growth.”
About joimax®
Founded in Karlsruhe, Germany, in 2001, joimax® is the
leading developer and marketer of complete systems for full-endoscopic
and minimally invasive spinal surgery. With the Endoscopic Surgical
Systems TESSYS® (transforaminal), iLESSYS®
(interlaminar) and CESSYS® (cervical) for decompression
procedures, MultiZYTE® for facet and sacroiliac joint pain
treatment and EndoLIF® and Percusys® for
minimally-invasive endoscopically assisted stabilizations, established
systems are provided, addressing a whole range of indications.
In procedures for herniated disc, stenosis, pain therapy or spinal
stabilization treatment, surgeons utilize joimax®
technologies to operate through small incisions under local or full
anesthesia, via tissue and muscle-sparing corridors and through natural
openings in the spinal canal, e.g. the intervertebral foramen, the
so-called “Kambin triangle”.
Contacts
Press Contact Germany:
joimax® GmbH
Sabine Jarosch
[email protected]
0049.721.25514
0
Press Contact USA:
joimax® Inc.
Emily Campbell
[email protected]
001.949.859.3472
Continues International Growth Strategy
KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the Germany-based market leader of technologies and
training methods for full-endoscopic, minimally-invasive spinal surgery,
is presenting its complete product portfolio at the 48th
Annual Meeting of the Japanese Society for Spine Surgery and Related
Research (JSSR, http://www.jssr.gr.jp/english/).
The annual meeting is currently underway running April 18-20, 2019 in
Yokohama, Japan.
Earlier this year, joimax® announced its partnership with
United Biomech Japan, Inc., who is overseeing distribution of the
complete joimax® product line throughout Japan. Approval of
the Pharmaceutical Medicals and Medical Devices Agency (PMDA) is
expected within the next couple of months.
“The Japanese market is characterized by a strong demand for innovative
products on endoscopic spinal surgery,” explained United Biomech Japan,
Inc. Executive Kazuya Oribe. “The interest at our booth is overwhelming.
There are approximately one thousand Japanese surgeons that are now
already interested in doing endoscopic spinal surgery.”
“The patients’ demand for gentle surgery methods that result in a very
quick recovery, is continuously increasing,” said joimax®
Group Founder and CEO Wolfgang Ries. “Our entrance into the Japanese
market is another milestone in expanding our global presence to offer
superior medical products. Coupled with an outstanding, international
training and education program, we’ve positioned ourselves for long-term
growth.”
About joimax®
Founded in Karlsruhe, Germany, in 2001, joimax® is the
leading developer and marketer of complete systems for full-endoscopic
and minimally invasive spinal surgery. With the Endoscopic Surgical
Systems TESSYS® (transforaminal), iLESSYS®
(interlaminar) and CESSYS® (cervical) for decompression
procedures, MultiZYTE® for facet and sacroiliac joint pain
treatment and EndoLIF® and Percusys® for
minimally-invasive endoscopically assisted stabilizations, established
systems are provided, addressing a whole range of indications.
In procedures for herniated disc, stenosis, pain therapy or spinal
stabilization treatment, surgeons utilize joimax®
technologies to operate through small incisions under local or full
anesthesia, via tissue and muscle-sparing corridors and through natural
openings in the spinal canal, e.g. the intervertebral foramen, the
so-called “Kambin triangle”.
Contacts
Press Contact Germany:
joimax® GmbH
Sabine Jarosch
[email protected]
0049.721.25514
0
Press Contact USA:
joimax® Inc.
Emily Campbell
[email protected]
001.949.859.3472
